Researchers examined the original framework of the NHS Diabetes Prevention Programme (DPP) implemented in the UK.
Ono Pharmaceutical acquires Deciphera for $2.4B after biotech’s Phase 3 win
Japanese drugmaker Ono Pharmaceutical is acquiring cancer-focused biotech Deciphera Pharmaceuticals for $2.4 billion, the companies announced Monday morning. The deal will see Ono acquire all